Sera Prognostics (SERA) Research & Development (2020 - 2026)
Sera Prognostics (SERA) reported Research & Development of $3.0 million for Q1 2026, down 9.12% on a YoY basis from $3.3 million in Q1 2025, and down 5.78% quarter-over-quarter from $3.2 million in Q4 2025.
Sera Prognostics (SERA) Research & Development (2020 - 2026) Analysis & Trends
Sera Prognostics has reported Research & Development for 7 years, with the latest figure at $3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 9.12% year-over-year to $3.0 million; the trailing twelve-month figure through Mar 2026 stood at $12.9 million (down 10.53% YoY), and the FY2025 full-year result was $13.2 million, down 10.58% from the prior year.
- Research & Development for Q1 2026 stood at $3.0 million, down from $3.2 million in the prior quarter.
- The five-year high for Research & Development was $4.4 million in Q2 2024, with the low at $3.0 million in Q1 2026.
- Historically, Research & Development has averaged $3.6 million across 5 years, with a median of $3.5 million in 2022.
- Annual changes were most pronounced in 2022 — Research & Development soared 53.3% — and 2025, when it slipped 24.26%.
- Sera Prognostics' Research & Development stood at $3.5 million in 2022, then grew by 11.76% to $3.9 million in 2023, then dropped by 19.41% to $3.1 million in 2024, then increased by 2.45% to $3.2 million in 2025, then fell by 5.78% to $3.0 million in 2026.
- The last three Research & Development figures came in at $3.0 million (Q1 2026), $3.2 million (Q4 2025), and $3.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 767.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 413.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 722.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 516.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 263.30 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | -461.27 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.30 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 345.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 28.80 Mn |
| 10 | Sera Prognostics | 93.48 Mn | 93.48 Mn | -28,000.00 | 3.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.03 Mn |
| Dec 31, 2025 | 3.22 Mn |
| Sep 30, 2025 | 3.28 Mn |
| Jun 30, 2025 | 3.34 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.50 Mn |
| Jun 30, 2024 | 4.41 Mn |
| Mar 31, 2024 | 3.68 Mn |
| Dec 31, 2023 | 3.90 Mn |
| Sep 30, 2023 | 3.54 Mn |
| Jun 30, 2023 | 3.69 Mn |
| Mar 31, 2023 | 4.10 Mn |
| Dec 31, 2022 | 3.49 Mn |
| Sep 30, 2022 | 4.18 Mn |
| Jun 30, 2022 | 3.26 Mn |
| Mar 31, 2022 | 3.32 Mn |
| Dec 31, 2021 | 3.08 Mn |
| Sep 30, 2021 | 2.72 Mn |
| Jun 30, 2021 | 2.82 Mn |